Nuvalent Inc. (NUVL)
NASDAQ: NUVL
· Real-Time Price · USD
76.36
-1.88 (-2.40%)
At close: Jun 16, 2025, 3:59 PM
76.32
-0.05%
After-hours: Jun 16, 2025, 04:45 PM EDT
-2.40% (1D)
| Bid | 68.64 |
| Market Cap | 5.48B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -300.86M |
| EPS (ttm) | -4.62 |
| PE Ratio (ttm) | -16.53 |
| Forward PE | -15.73 |
| Analyst | Buy |
| Ask | 84.4 |
| Volume | 384,197 |
| Avg. Volume (20D) | 572,360 |
| Open | 77.81 |
| Previous Close | 78.24 |
| Day's Range | 75.90 - 78.94 |
| 52-Week Range | 55.53 - 113.51 |
| Beta | 1.34 |
About NUVL
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NUVL
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NUVL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts9 months ago
-6.61%
Nuvalent shares are trading lower after the compan...
Unlock content with
Pro Subscription
9 months ago
+28.27%
Nuvalent shares are trading higher after the company highlighted results for its ROS1 and ALK-Positive NSCLC programs and accelerated its development timeline. Also, the company announced a $350 million public offering and multiple firms raised their respective price targets on the stock.
